What is the recommended dose of thiamine (Vitamin B1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Thiamine (Vitamin B1) Dosing

The recommended thiamine dosage varies by clinical scenario, with maintenance doses of 50-100 mg/day orally for proven deficiency, while acute conditions like Wernicke encephalopathy require 500 mg IV three times daily for 3-5 days. 1, 2

Standard Dosing Recommendations

Preventive/Maintenance Dosing

  • Standard nutritional supplementation:
    • Enteral nutrition: 1.5-3 mg/day (for patients receiving 1500 kcal/day) 1
    • Parenteral nutrition: At least 2.5 mg/day 1
  • Maintenance dose for proven deficiency: 50-100 mg/day orally 1, 2
  • Mild deficiency/depletion: 10 mg/day orally for one week 1

Therapeutic Dosing for At-Risk Patients

  • Hospitalized patients/critical illness: 100-300 mg/day IV 1
  • Refeeding syndrome: 300 mg IV before initiating nutrition therapy, followed by 200-300 mg IV daily for at least 3 more days 1
  • Continuous renal replacement therapy: 100 mg/day 1
  • Patients at risk of deficiency (reduced food intake, high alcohol consumption): 100-300 mg/day oral or IV 1

Therapeutic Dosing for Suspected/Confirmed Deficiency

  • Wernicke encephalopathy:
    • 500 mg IV three times daily for 3-5 days, followed by 250 mg IV daily for at least 3-5 additional days 2, 3
    • Alternative regimen: 100 mg initially, followed by 50-100 mg IM daily until regular diet is consumed 3
  • High suspicion or proven deficiency: 200 mg three times daily IV 2
  • "Wet" beriberi with myocardial failure: 10-20 mg IM three times daily for up to two weeks 3
  • Neuritis of pregnancy with severe vomiting: 5-10 mg IM daily 3

Special Clinical Scenarios

Alcoholic Patients

  • Low risk (uncomplicated alcohol dependence): 250-500 mg/day oral for 3-5 days, followed by 100-250 mg/day oral 4
  • High risk of thiamine deficiency: 250-500 mg/day parenteral for 3-5 days, followed by 250-300 mg/day oral 4
  • Suspected Wernicke encephalopathy: 250-300 mg parenteral twice daily for 3-5 days, followed by 250-300 mg/day oral 4
  • Established Wernicke encephalopathy: 200-500 mg parenteral three times daily for 3-5 days, followed by 250-1000 mg/day oral 4

Patients Receiving Dextrose

  • Before dextrose administration: 100 mg IV thiamine in each of the first few liters of IV fluid to avoid precipitating heart failure 3

Important Clinical Considerations

  • Thiamine should always be administered before initiating nutritional support in at-risk patients 2
  • For acute conditions, IV route is preferred for maximum efficacy 1, 2
  • Oral route is adequate for chronic deficiency without acute disease 1
  • No upper limit for toxicity has been established; excess is excreted in urine 1
  • High IV doses have rarely led to anaphylaxis 1
  • Doses exceeding 400 mg may cause nausea, anorexia, and mild ataxia 1

Monitoring

  • Thiamine status should be determined by measuring RBC or whole blood thiamine diphosphate (ThDP) 1
  • Consider thiamine assessment in patients with:
    • Cardiomyopathy with prolonged diuretic treatment
    • Prolonged medical nutrition or post-bariatric surgery
    • Refeeding syndrome
    • Encephalopathy 1

High-dose thiamine (≥500 mg) appears safe and effective for patients with suspected Wernicke encephalopathy, with studies showing symptom improvement in approximately 73% of patients 5. Early treatment is critical to prevent progression to irreversible Korsakoff syndrome 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nutrition and Vitamin Supplementation in High-Risk Populations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Thiamine (vitamin B1) treatment in patients with alcohol dependence].

Presse medicale (Paris, France : 1983), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.